Sinclair Pharma PLC Holding(s) in Company (0322G)
24 May 2017 - 4:01PM
UK Regulatory
TIDMSPH
RNS Number : 0322G
Sinclair Pharma PLC
24 May 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
1. Identity of the issuer or Sinclair Pharma Plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
--------------------------------------------------------- -------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights YES
------------------------------------------------------------- ---------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------- ---------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------- ---------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------- ---------------------------
Other (please
specify):
-------------------------------------------------------- --- ---------------------------
3. Full name of person(s) Toscafund Asset Management
subject to the LLP
notification obligation:
(iii)
--------------------------------------------------------- -------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv) TOSCA MID CAP
TOSCA OPPORTUNITY
THE PEGASUS FUND LIMITED
--------------------------------------------------------- -------------------------------
5. Date of the transaction 19/05/2017
and date on
which the threshold is
crossed or
reached: (v)
--------------------------------------------------------- -------------------------------
6. Date on which issuer 23/05/2017
notified:
--------------------------------------------------------- -------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 25%
--------------------------------------------------------- -------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ----------------------------------- ------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- ---------------- ----------------- -------------- ----------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ------------ ------------- -------------- --------- ------------ ------------ -----------
GB0033856740 137,531,386 137,531,386 127,296,386 0 127,296,386 0 25.3%
------------- ---------------- ----------------- -------------- --------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- -------------- --------------------------------- ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- -------------- --------------- ---------------- ------------------------- -----------------------
Nominal Delta
--------------- -------------- --------------- ---------------- ------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------- ----------------------------------------------------------------
127,296,386 25.3%
---------------------------------------------------- ----------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------
N/A
Proxy Voting:
-----------------------------------------------------------------------
10. Name of the proxy holder: N/A
------------------------------------------------------- --------------
11. Number of voting rights proxy N/A
holder will cease
to hold:
------------------------------------------------------- --------------
12. Date on which proxy holder will N/A
cease to hold
voting rights:
------------------------------------------------------- --------------
13. Additional information: None
------------------------------------------------------- --------------
14. Contact name: Robert Lord
------------------------------------------------------- --------------
15. Contact telephone number: 020 7845 6100
------------------------------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLAJMRTMBJTBPR
(END) Dow Jones Newswires
May 24, 2017 02:01 ET (06:01 GMT)
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From Apr 2024 to May 2024
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Sinclair Pha (London Stock Exchange): 0 recent articles
More Sinclair Pha News Articles